Gilead Sciences -- Payments to Infectious Disease Physicians
This page provides a detailed breakdown of Gilead Sciences's payments to Infectious Disease physicians, as reported in the CMS Open Payments (Sunshine Act) database. Understanding how a pharmaceutical company targets specific medical specialties reveals important patterns about their marketing strategies and physician relationships.
Payment Summary: Gilead Sciences to Infectious Disease
- Total Payments to Infectious Disease Doctors: $2,012,990.30
- Number of Transactions: 159
- Number of Infectious Disease Doctors Paid: 20
- Average Payment Amount: $12,660.32
- Share of Gilead Sciences's Total Spending: 20.1% of $10.0M
Why Does Gilead Sciences Pay Infectious Disease Doctors?
Pharmaceutical companies make payments to physicians in specialties related to their product portfolio. Gilead Sciences's payments to Infectious Disease specialists may include consulting fees for drug development advice, speaking engagements at medical conferences, clinical trial research funding, and meals during product education visits. The volume and types of payments to Infectious Disease doctors can indicate the importance of this specialty to Gilead Sciences's business strategy.
Understanding the relationship between Gilead Sciences and Infectious Disease physicians helps patients evaluate whether their doctor's prescribing patterns might be influenced by financial relationships with this company.
Payment Types: How Gilead Sciences Pays Infectious Disease Doctors
The following table shows the breakdown of payment categories from Gilead Sciences to Infectious Disease physicians:
| Payment Type | Total Amount | Transactions |
|---|---|---|
| Ownership Interest | $767,634.27 | 3 |
| Consulting Fees | $663,335.69 | 42 |
| Speaking & Education | $254,225.14 | 11 |
| Research Funding | $216,427.97 | 3 |
| general | $64,681.43 | 37 |
| Travel & Lodging | $40,343.21 | 14 |
| Food & Beverage | $6,342.59 | 49 |
Top Infectious Disease Doctors Paid by Gilead Sciences
The following Infectious Disease physicians have received the largest total payments from Gilead Sciences. Click on any physician to view their complete payment report.
| Physician | Total Received | Transactions |
|---|---|---|
| Gregory Evans | $279,484.85 | 1 |
| Rachel Parker | $279,123.18 | 1 |
| Lisa Garcia | $209,026.24 | 1 |
| Robert Johnson | $107,730.34 | 1 |
| Rachel Parker | $101,872.63 | 1 |
| Rebecca Adams | $43,269.78 | 1 |
| Daniel White | $40,640.49 | 1 |
| Sarah Chen | $30,961.39 | 1 |
| Heather Mitchell | $30,640.70 | 1 |
| Rebecca Adams | $29,645.92 | 1 |
| Jessica Moore | $29,439.59 | 1 |
| Christine Edwards | $29,103.18 | 1 |
| Robert Johnson | $27,721.59 | 1 |
| David Kim | $27,112.20 | 1 |
| Amy Phillips | $26,325.59 | 1 |
| Paul Turner | $26,226.17 | 1 |
| Charles Baker | $25,371.95 | 1 |
| Scott Collins | $25,170.90 | 1 |
| Joseph Carter | $25,125.84 | 1 |
| Paul Turner | $24,508.78 | 1 |
Recent Payments from Gilead Sciences to Infectious Disease Physicians
| Doctor | Amount | Type | Drug/Device | Date |
|---|---|---|---|---|
| Nicole Lopez | $64.58 | meals | N/A | 2026-04-09 |
| Sarah Chen | $30,961.39 | consulting | N/A | 2026-03-31 |
| Steven Green | $1,761.57 | general | N/A | 2026-03-28 |
| Ashley Nelson | $2,982.36 | general | N/A | 2026-03-26 |
| Heather Mitchell | $1,323.30 | travel | N/A | 2026-03-18 |
| Charles Baker | $8,068.29 | consulting | N/A | 2026-03-16 |
| Robert Johnson | $107,730.34 | research | N/A | 2026-03-10 |
| Charles Baker | $237.69 | meals | N/A | 2026-03-01 |
| Christine Edwards | $230.38 | meals | N/A | 2026-02-22 |
| Jessica Moore | $2,967.35 | travel | N/A | 2026-02-19 |
| Melissa Reed | $93.17 | meals | N/A | 2026-02-18 |
| Lisa Garcia | $1,650.35 | general | N/A | 2026-02-13 |
| Elizabeth Roberts | $2,755.87 | general | N/A | 2026-02-05 |
| Nicole Lopez | $62.79 | meals | N/A | 2026-02-05 |
| Melissa Reed | $1,679.91 | general | N/A | 2026-02-02 |
Frequently Asked Questions
How much does Gilead Sciences pay Infectious Disease doctors?
According to CMS Open Payments data, Gilead Sciences has made $2,012,990.30 in payments to Infectious Disease physicians across 159 transactions. The average payment is $12,660.32. These payments include consulting fees, speaking engagements, meals, research funding, and other transfers of value required to be reported under the Sunshine Act.
Which Infectious Disease doctors receive the most from Gilead Sciences?
The top Infectious Disease physician receiving payments from Gilead Sciences is Gregory Evans, with $279,484.85 across 1 transactions. View the full ranking table above for all Infectious Disease doctors paid by Gilead Sciences.
Why does Gilead Sciences target Infectious Disease specialists?
Pharmaceutical companies target medical specialties related to their product portfolio. Gilead Sciences's payments to Infectious Disease doctors likely relate to drugs or devices used in infectious disease practice. These payments can include advisory board fees, clinical trial funding, and educational speaking engagements.
Should I be concerned if my Infectious Disease doctor takes money from Gilead Sciences?
Payment from Gilead Sciences to a Infectious Disease physician does not imply wrongdoing. Many payments represent legitimate professional activities like research and medical education. However, patients may want to ask their doctor about these relationships, especially if Gilead Sciences products are being prescribed. Transparency helps patients have informed conversations with their physicians.
How does Gilead Sciences's Infectious Disease spending compare to other pharma companies?
Gilead Sciences has spent $2,012,990.30 on Infectious Disease physicians. To compare with other pharmaceutical companies, visit the Infectious Disease specialty page for a broader view of which companies spend the most on this medical specialty.
Related Reports
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice.